![]() Amal Therapeutics Amal Therapeutics is a biotech company, which engages in the research and development of therapeutic vaccines in oncology. | ![]() Polynoma Polynoma is an immuno-oncology company developing seviprotimut-L, a polyvalent antigen therapy for the treatment of melanoma. | ![]() NKGen Biotech NKGen Biotech (formerly known as NKMax America) is a biotechnology company that develops cell therapies for neurodegenerative and oncological diseases based on activated NK cells. | |||
Founding Date | Founding Date 2012 | Founding Date N/A | Founding Date 2007 | Founding Date 2017 | Founding Date 2018 |
Type | Type Public | Type Subsidiary | Type Subsidiary | Type Public | Type Private |
Tags | |||||
Locations | Locations Kew East, AU HQ South Melbourne, AU | Locations Genève, CH HQ | Locations San Diego, US HQ | Locations Santa Ana, US HQ | Locations San Francisco, US HQ |
Employees | Employees 325% decrease | Employees 254% decrease | Employees 2 | Employees 7316% increase | Employees 3 |
Valuation ($) | Valuation ($) 18.4 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 11 m | Valuation ($) N/A |
Financial | |||||
Net income | Net income ($8.8m) (FY, 2025) | Net income N/A | Net income N/A | Net income ($44.3m) (FY, 2024) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 45.5m | Total funding raised N/A | Total funding raised $ 11m | Total funding raised $ 42m |

Amal Therapeutics is a biotech company, which engages in the research and development of therapeutic vaccines in oncology.
View company
Polynoma is an immuno-oncology company developing seviprotimut-L, a polyvalent antigen therapy for the treatment of melanoma.
View company
NKGen Biotech (formerly known as NKMax America) is a biotechnology company that develops cell therapies for neurodegenerative and oncological diseases based on activated NK cells.
View company
Soteria Biotherapeutics is a company specializing in immunotherapies.
View company